Saturday, 25 June 2022

BMS, Pfizer to present clinical trials data on Eliquis

22 August 2014 | News | By BioSpectrum Bureau

BMS, Pfizer to present clinical trials data on Eliquis

(Photo Courtesy: www.ncip.nci.nih.gov)

(Photo Courtesy: www.ncip.nci.nih.gov)

The new clinical trial data and New Global Health Economics and Outcomes Research (GHEOR) analyses assessing cost effectiveness and real-world use to reinforce the alliance's commitment to the ongoing analysis of Eliquis in both the nonvalvular atrial fibrillation (NVAF) and venous thromboembolism (VTE).

BMS in a statement also said that 14 abstracts will be presented, including new analysis from the ARISTOTLE, AMPLIFY and AMPLIFY-EXT trials evaluating patients with NVAF and VTE.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account